Seminar video: I.T. and life science patentability requirements following ‘Myriad’, ‘Prometheus’ & ‘
The definition of patentable subject matter in the USA has recently been clarified in three major US court cases: 'AMP v Myriad Genetics', 'Mayo v Prometheus' and 'CLS Bank v Alice Corp'.
If you are interested in the US market, it will be crucial that your patent strategies meet these definitions of what now constitutes patentable subject matter.
Below is a video of a seminar hosted by Davies Collison Cave in Sydney on the topic of Patent Strategy in the time of 'Myriad', 'Prometheus' And 'Alice Corp'. Gavin Recchia Chaired the seminar, while Bill Pickering and Sam Mickan provided an outline of the revised definitions and discussed their impact on patent strategies in the bio science and software/business method fields.
Should you have any questions in relation to any of the items mentioned in the presentation please feel free to contact the speakers or seminar chairman:
03 9254 2610
03 9254 2520
02 9293 1045